These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21999735)

  • 1. Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries.
    Foti Cuzzola V; Ciurleo R; Giacoppo S; Marino S; Bramanti P
    CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):849-62. PubMed ID: 21999735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol: its biologic targets and functional activity.
    Pervaiz S; Holme AL
    Antioxid Redox Signal; 2009 Nov; 11(11):2851-97. PubMed ID: 19432534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
    Fantacuzzi M; Amoroso R; Carradori S; De Filippis B
    Eur J Med Chem; 2022 Apr; 233():114242. PubMed ID: 35276424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.
    Lim KG; Gray AI; Anthony NG; Mackay SP; Pyne S; Pyne NJ
    Arch Toxicol; 2014 Dec; 88(12):2213-32. PubMed ID: 25344023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol as a protective molecule for neuroinflammation: a review of mechanisms.
    Renaud J; Martinoli MG
    Curr Pharm Biotechnol; 2014; 15(4):318-29. PubMed ID: 24938890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection.
    Pallàs M; Casadesús G; Smith MA; Coto-Montes A; Pelegri C; Vilaplana J; Camins A
    Curr Neurovasc Res; 2009 Feb; 6(1):70-81. PubMed ID: 19355928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol as a therapeutic agent for neurodegenerative diseases.
    Sun AY; Wang Q; Simonyi A; Sun GY
    Mol Neurobiol; 2010 Jun; 41(2-3):375-83. PubMed ID: 20306310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease.
    Huang FC; Kuo HC; Huang YH; Yu HR; Li SC; Kuo HC
    BMC Pharmacol Toxicol; 2017 Jan; 18(1):3. PubMed ID: 28069066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pterostilbene and resveratrol on brain and behavior.
    Poulose SM; Thangthaeng N; Miller MG; Shukitt-Hale B
    Neurochem Int; 2015 Oct; 89():227-33. PubMed ID: 26212523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the Therapeutic and Pharmacological Properties of Resveratrol as a Nutraceutical Antioxidant Polyphenol in Health Promotion and Disease Prevention.
    Mohammadi S; Moghadam MD; Nasiriasl M; Akhzari M; Barazesh M
    Curr Rev Clin Exp Pharmacol; 2024; 19(4):327-354. PubMed ID: 38192151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique properties of polyphenol stilbenes in the brain: more than direct antioxidant actions; gene/protein regulatory activity.
    Doré S
    Neurosignals; 2005; 14(1-2):61-70. PubMed ID: 15956815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation.
    Zhang F; Liu J; Shi JS
    Eur J Pharmacol; 2010 Jun; 636(1-3):1-7. PubMed ID: 20361959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-core nanocapsules improve the effects of resveratrol against Abeta-induced neuroinflammation.
    Frozza RL; Bernardi A; Hoppe JB; Meneghetti AB; Battastini AM; Pohlmann AR; Guterres SS; Salbego C
    J Biomed Nanotechnol; 2013 Dec; 9(12):2086-104. PubMed ID: 24266263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent patents in CNS drug discovery: the management of inflammation in the central nervous system.
    Nimmo AJ; Vink R
    Recent Pat CNS Drug Discov; 2009 Jun; 4(2):86-95. PubMed ID: 19519558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol Attenuates Acute Inflammatory Injury in Experimental Subarachnoid Hemorrhage in Rats via Inhibition of TLR4 Pathway.
    Zhang XS; Li W; Wu Q; Wu LY; Ye ZN; Liu JP; Zhuang Z; Zhou ML; Zhang X; Hang CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.
    Shankar S; Singh G; Srivastava RK
    Front Biosci; 2007 Sep; 12():4839-54. PubMed ID: 17569614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common pathways in health benefit properties of RSV in cardiovascular diseases, cancers and degenerative pathologies.
    Aires V; Delmas D
    Curr Pharm Biotechnol; 2015; 16(3):219-44. PubMed ID: 25601605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular effects of resveratrol in health and disease.
    Yu W; Fu YC; Wang W
    J Cell Biochem; 2012 Mar; 113(3):752-9. PubMed ID: 22065601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective properties of resveratrol in different neurodegenerative disorders.
    Albani D; Polito L; Signorini A; Forloni G
    Biofactors; 2010; 36(5):370-6. PubMed ID: 20848560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.